Neoadjuvant Chemoimmunotherapy Clinical Trials

24 clinical trials for Neoadjuvant Chemoimmunotherapy across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Imaging-based PRediction of Eligibility for ChemoImmunotherapy in reSEctable NSCLC, iPRECISE — RECRUITING
• RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC — RECRUITING
• Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC — RECRUITING
• Tumor Margin Skin Tattooing Before Neo-adjuvant Chemotherapy in Patients With Breast Cancer — RECRUITING · NA
• Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05) — RECRUITING · PHASE2
• NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study — RECRUITING · PHASE1
• Neoadjuvant Immunochemotherapy in PD-L1-negative LACC — RECRUITING · PHASE2
• Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer — RECRUITING · PHASE2
• Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC — RECRUITING · PHASE2
• Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer — RECRUITING · PHASE2
• Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma — RECRUITING · PHASE2
• Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma — RECRUITING
• Microbiota in Neoadjuvant Chemoimmunotherapy for NSCLC — NOT_YET_RECRUITING
• Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response — NOT_YET_RECRUITING · PHASE2
• Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC. — NOT_YET_RECRUITING · PHASE3
• Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study — NOT_YET_RECRUITING · PHASE2
• Simplified Exercise-based Risk Assessment in Lung Cancer — NOT_YET_RECRUITING
• Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base — NOT_YET_RECRUITING · PHASE2
• Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study — NOT_YET_RECRUITING · PHASE2
• Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction Carcinoma — NOT_YET_RECRUITING · NA
• Mechanism Study to Investigate Difference in Efficacy of Neoadjuvant Chemoimmunotherapy in Lung Squamous Cell Carcinoma — OTHER
• Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy — OTHER
• Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer — OTHER

Refine this search